2021
-
05
-
24
點(diǎn)擊次數(shù):
中國醫(yī)藥城,地處江蘇泰州，是中國首個(gè)國家級(jí)醫(yī)藥高新區(qū)，由科技部、衛(wèi)健委、國家藥品監(jiān)督管理局、國家中醫(yī)藥管理局與江蘇省人民政府共同建設(shè)。中國醫(yī)藥城致力于打造中國規(guī)模最大、產(chǎn)業(yè)鏈最完善的生物醫(yī)藥產(chǎn)業(yè)基地。CMC已經(jīng)與70余家國內(nèi)外知名機(jī)構(gòu)合作，落戶企業(yè)達(dá)到100余家，包括：區(qū)內(nèi)已集聚阿斯利康、勃林格殷格翰、雀巢、賽諾菲巴斯德、武田制藥、中外制藥、安若維他、臺(tái)灣桑堤亞、石藥集團(tuán)、海王集團(tuán)、沃森生物、大同盟制藥、邁博太科、中崇集團(tuán)、華威特等等。The China Medical City（CMC） located in Taizhou. As the first national level life science hi-tech park, the CMC is jointly built by the Ministry of Science and Technology, the National Health Commission of the People5 s Repubic of China, the National Medical Products Administration, the China Administration of Traditional Chinese Medicine and Jiangsu Provincial Government.We are committed to building the largest life science industrial base with the most integrated industrial chain in China. The CMC has cooperated with over 70 famous life science research and development institutes at home and abroad, and over 1000 companies with a large number of major industrial projects have been introduced in CMC, including AstraZeneca, Boehringer Ingelheim, Nestle, Sanofi-Pasteur, Takeda, Chugai, Aurovitas, Taiwan Xantia, Neptunus Group, Watson, Mabtech, Zhongchong group, Sinovet etc.